Lirilumab (IPH2102) is a monoclonal antibody targeting KIR (Killer-cell Immunoglobulin-like Receptors), demonstrating significant antitumor activity. This antibody is specifically designed for research applications focusing on leukemia and squamous cell carcinoma of the head and neck (SCCHN), providing a valuable tool for studies aimed at understanding and potentially modulating immune responses in these cancers.
Lirilumab (IPH2102) is a monoclonal antibody targeting KIR (Killer-cell Immunoglobulin-like Receptors), demonstrating significant antitumor activity. This antibody is specifically designed for research applications focusing on leukemia and squamous cell carcinoma of the head and neck (SCCHN), providing a valuable tool for studies aimed at understanding and potentially modulating immune responses in these cancers.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
